-
COLL Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Collegium Pharmaceutical (COLL)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 96.61 mm | 96.61 mm | 96.61 mm | 96.61 mm | 96.61 mm | 96.61 mm |
Cash burn (monthly) | (no burn) | 11.95 mm | (no burn) | (no burn) | (no burn) | (no burn) |
Cash used (since last report) | n/a | 24.73 mm | n/a | n/a | n/a | n/a |
Cash remaining | n/a | 71.88 mm | n/a | n/a | n/a | n/a |
Runway (months of cash) | n/a | 6.0 | n/a | n/a | n/a | n/a |
13F holders | Current |
---|---|
Total holders | 239 |
Opened positions | 35 |
Closed positions | 45 |
Increased positions | 70 |
Reduced positions | 93 |
13F shares | Current |
---|---|
Total value | 1.04 tn |
Total shares | 39.90 mm |
Total puts | 9.50 k |
Total calls | 17.80 k |
Total put/call ratio | 0.5 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 5.56 mm | $159.17 bn |
Eventide Asset Managment | 2.64 mm | $75.60 bn |
Rubric Capital Management | 2.35 mm | $67.33 bn |
Vanguard | 2.28 mm | $65.40 bn |
Pacer Advisors | 2.14 mm | $61.38 bn |
IVZ Invesco | 1.78 mm | $50.88 bn |
Principal Global Investors | 1.75 mm | $60.52 mm |
Renaissance Technologies | 1.66 mm | $47.60 bn |
PFG Principal Financial | 1.65 mm | $47.13 bn |
STT State Street | 1.44 mm | $41.17 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
10 Feb 25 | Kuhlmann Shirley R. | Common Stock | Payment of exercise | Dispose F | No | No | 30.52 | 25,149 | 767.55 k | 154,204 |
10 Feb 25 | Kuhlmann Shirley R. | Common Stock | Payment of exercise | Dispose F | No | No | 30.52 | 9,826 | 299.89 k | 179,353 |
10 Feb 25 | Kuhlmann Shirley R. | Common Stock | Grant | Acquire A | No | No | 0 | 29,030 | 0.00 | 189,179 |
10 Feb 25 | Kuhlmann Shirley R. | Common Stock | Grant | Acquire A | No | No | 0 | 40,965 | 0.00 | 160,149 |
10 Feb 25 | Colleen Tupper | Common Stock | Payment of exercise | Dispose F | No | No | 30.52 | 22,317 | 681.11 k | 179,144 |
10 Feb 25 | Colleen Tupper | Common Stock | Payment of exercise | Dispose F | No | No | 30.52 | 8,109 | 247.49 k | 201,461 |
10 Feb 25 | Colleen Tupper | Common Stock | Grant | Acquire A | No | No | 0 | 26,957 | 0.00 | 209,570 |
10 Feb 25 | Colleen Tupper | Common Stock | Grant | Acquire A | No | No | 0 | 51,768 | 0.00 | 182,613 |
10 Feb 25 | Heffernan Michael Thomas | Common Stock | Grant | Acquire A | No | No | 0 | 4,820 | 0.00 | 50,328 |
10 Feb 25 | Thomas B Smith | Common Stock | Payment of exercise | Dispose F | No | No | 30.52 | 4,399 | 134.26 k | 87,742 |